Sender CO & Partners, Inc. Harpoon Therapeutics, Inc. Transaction History

Sender CO & Partners, Inc.

  • $41.4 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 17, 2022
SELL
$3.54 - $8.08 $50,452 - $115,156
-14,252 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$5.69 - $7.83 $81,093 - $111,593
14,252 New
14,252 $108,000

Others Institutions Holding HARP

# of Institutions
2
Shares Held
353K
Call Options Held
0
Put Options Held
0
View Full List

About Harpoon Therapeutics, Inc.

HARP Quotes by TradingView
  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Sender CO & Partners, Inc. Portfolio

Follow Sender CO & Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sender CO & Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sender CO & Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email